MarketStudyReport.com offers 2018 report on Global Cell Line Development market that evaluates industry growth trends through historical data and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2024.
—
Market Study Report adds 2018-2024 Global Cell Line Development market report that offers an exhaustive coverage of the industry with brief analysis, data charts, figures, statistics that help take business decisions, company profiles and more.
U.S. cell line development market valued around USD 1.1 billion in 2017 and estimated to grow considerably during the forecast timeframe. Launch of sophisticated cell line development technologies, well-established healthcare infrastructure and large-scale production of protein therapeutics will drive the U.S. cell line development market during the forecast timeframe.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467705/
Advancement in rDNA technology has escalated demand for recombinant cell lines. Moreover, several applications of rDNA technology including production of various biological products such as enzymes, immunobiological, synthetic hormones and various other anti-cancer agents will drive recombinant cell line type segment during the forecast timeframe.
Reagents and media product segment dominated the industry in 2017 owing to high usage of reagents and media in tissue engineering, toxicity testing, research, bioproduction, development of regenerative medicine and others. It forms essential component for cell line development and cell culture procedures will drive industry growth. Non-mammalian source segment is estimated to grow considerably during the forecast period owing to high application in insecticide screening and toxicology study.
Few notable industry players operating in cell line development market are GE Healthcare, Thermo Fisher Scientific, Lonza Group, Sigma-Aldrich Corporation (Merck), Cytovance Biologics, WuXi AppTec, Sartorius, Corning, Selexis, Vista Biologicals, EuBiologics, Paragon Bioservices, Cobra Biologics, Patheon, Samsung Biologics, NAEJA RGM Pharmaceuticals, GVK BIO, Catalent
Based on application type, the industry is bifurcated into bioproduction, toxicity testing, drug discovery, tissue engineering and research. Tissue engineering segment will witness robust growth rate during the forecast period due to increasing investment in R&D coupled with rising demand for advanced cancer treatment.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467705/
High incident rate of cancer, favorable reimbursement for biologics and rising demand for monoclonal antibodies, vaccines and gene therapy will drive France cell line development market over the coming years. Presence of associations such as The French National Cancer Institute (INCa) working towards reducing cancer prevalence will positively impact the industry growth.
Increasing incidences of cancer coupled with growing demand for monoclonal antibodies and vaccines will drive cell line development market. Rising prevalence of cancer has become major healthcare concern globally, hence government and several other organizations are conducting extensive research to reduce disease burden one of such approach includes cancer cell line development.
Table of Content:
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data Sources
1.4.1. Secondary
1.4.1.1. Paid Sources
1.4.1.2. Unpaid Sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Cell line development industry 360 degree synopsis, 2013 – 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Source trends
2.1.4. Cell line type trends
2.1.5. Application trends
2.1.6. Regional trends
Chapter 3. Cell Line Development Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rise in production of vaccines globally
3.3.1.2. Increasing number of cancer incidences especially in developing countries such as India and China
3.3.1.3. Extended applications of biotechnology sector
3.3.1.4. Patent expiration of blockbuster biologics leading to innovations in the field
3.3.1.5. Escalating demand for monoclonal antibodies in U.S. and Europe
3.3.1.6. Technological advancements in cell line development
3.3.2. Industry pitfalls & challenges
3.3.2.1. Ambiguous regulatory landscape
3.3.2.2. Growing concerns related to stem cell research
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By source
3.4.3. By cell line type
3.4.4. By application
Chapter 4. Cell Line Development Market, By Product
4.1. Key segment trends
4.2. Reagents and media
4.2.1. Reagents and media market, by region, 2013 – 2024 (USD Million)
4.3. Equipment
4.3.1. Equipment market, by region, 2013 – 2024, (USD Million)
4.3.2. Incubators
4.3.2.1. Incubators market, by region, 2013 – 2024, (USD Million)
4.3.3. Centrifuges
4.3.3.1. Centrifuges market, by region, 2013 – 2024, (USD Million)
4.3.4. Bioreactors
4.3.4.1. Bioreactors market, by region, 2013 – 2024, (USD Million)
4.3.5. Storage equipment
4.3.5.1. Storage equipment market, by region, 2013 – 2024, (USD Million)
4.3.6. Microscopes
4.3.6.1. Microscopes market, by region, 2013 – 2024, (USD Million)
4.4. Accessories and consumables
4.4.1. Accessories and consumables market, by region, 2013 – 2024, (USD Million)
Chapter 5. Cell Line Development Market, By Source
5.1. Key segment trends
5.2. Mammalian
5.2.1. Mammalian cell line development market, by region, 2013 – 2024, (USD Million)
5.3. Non-mammalian
5.3.1. Non-mammalian cell development market, by region 2013 – 2024, (USD Million)
5.3.2. Insects
5.3.2.1. Insect cell line development market, by region 2013 – 2024, (USD Million)
5.3.3. Amphibians
5.3.3.1. Amphibians cell line development market, by region 2013 – 2024, (USD Million)
More Details on this Report At: https://www.marketstudyreport.com/reports/cell-line-development-market
Related Report:
Global Biotherapeutics Cell Line Development Market Size, Status and Forecast 2025
This report studies the global Biotherapeutics Cell Line Development market, analyzes and researches the Biotherapeutics Cell Line Development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Becton Dickinson & Company, Beckman Coulter, Boehringer Ingelheim Group & More.
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com
Source: MarketersMedia
Release ID: 463394
